The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 722.00
Bid: 721.00
Ask: 728.00
Change: 2.00 (0.28%)
Spread: 7.00 (0.971%)
Open: 758.00
High: 758.00
Low: 722.00
Prev. Close: 720.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

19 Mar 2020 07:00

RNS Number : 7068G
discoverIE Group plc
19 March 2020
 

For Release

7.00am, 19 March 2020

 

discoverIE Group plc

Year End Trading Update

 

 

discoverIE Group plc (LSE: DSCV, "discoverIE" or the "Group"), a leading international designer, manufacturer and supplier of customised electronics to industry, today issues a trading update for the year ending 31 March 2020.

Following strong momentum through the year, during the fourth quarter the Group has experienced some isolated disruption to the business as a result of the outbreak of the COVID-19 virus.

In China, the Group operates two manufacturing facilities in Guangdong province, and also has a number of Chinese suppliers and customers. Following an extended shut down after the Chinese New Year, the facilities are again operational, with production returning to planned levels. Similarly, our Chinese suppliers have recommenced operations and sales to our customers are returning to normal levels, with demand recovering quickly.

The Group's Design & Manufacturing division operates a diversified and flexible manufacturing footprint with additional facilities in India, Sri Lanka, Thailand, South Korea, Poland, Slovakia, the Netherlands, Belgium, UK, Germany, the Nordic region, Mexico, US and Canada, all of which are currently operating without major disruption. With the wellbeing of our employees being a priority and following local regulatory guidance, discoverIE's diversified businesses all have detailed business continuity plans and are maintaining operational continuity.

Aside from the Chinese disruption described above, trading elsewhere in the Group during the fourth quarter has been in line with our expectations, against a strong comparative period in the prior year, as we continue to benefit from the focus on our target markets. As a result, the disruption during the fourth quarter is expected to have a modest impact on our earnings for the year to 31 March 2020.

The Group benefits from a strong and diversified customer base, and demand remains robust with good new order intake in March. Whilst the Group is well prepared to respond quickly and effectively to mitigate any further disruption from the spread of COVID-19, the wider potential impacts entering the new financial year are difficult to predict. The Group remains well funded, with a strong balance sheet, good cash liquidity, over £100m of headroom against its debt facilities and gearing1 of 1.5x.

We are confident that our clear strategy focusing on the target markets of renewable energy, medical, transportation and industrial & connectivity to create sustainable organic growth will enable us to continue to outperform wider industrial markets and generate significant stakeholder value.

 

For further information, please contact:

 

discoverIE Group plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Instinctif

Mark Garraway

James Gray

01483 544 500

 

 

 

 

020 7457 2020

 

 

Notes

1. Gearing defined as net debt divided by underlying EBITDA, annualised for acquisitions.

 

2. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of discoverIE Group plc. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this update. Forward looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

3. The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation, Article 7 of EU Regulation 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Notes to Editors:

 

About discoverIE Group plc

 

discoverIE Group plc is an international group of businesses that designs, manufactures and supplies innovative components for electronic applications.

 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

 

By focusing on key markets driven by structural growth and increasing electronic content, namely renewable energy, transportation, medical and industrial & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with targeted complementary acquisitions.

 

The Group employs c.4,500 people and its principal operating units are located in Continental Europe, the UK, China, Sri Lanka, India and North America.

 

The Group is listed on the Main Market of the London Stock Exchange and is in the top quartile of the FTSE Small Cap Index, classified within the Electrical Components and Equipment subsector, and has revenues of over £400m. Over the last five years, revenue and underlying earnings per share have both more than doubled.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFFFAAESSEED
Date   Source Headline
17th Jun 20157:00 amRNSNotice of Site Visit
16th Jun 20157:00 amRNSDirectorate Change
4th Jun 201511:28 amRNSRe: Dividend
2nd Jun 20154:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20157:00 amRNSFinal Results
17th Apr 20157:01 amRNSAppointment of New Chairman
17th Apr 20157:00 amRNSTrading Update
12th Mar 20155:52 pmRNSHolding(s) in Company
23rd Feb 20157:00 amRNSBoard Appointment
9th Feb 20157:00 amRNSInterim Management Statement
27th Jan 201512:57 pmRNSHolding(s) in Company
7th Jan 20157:00 amRNSAcquisition
29th Dec 20147:00 amRNSHolding(s) in Company
27th Nov 20147:00 amRNSHalf Yearly Report
19th Nov 20144:17 pmRNSHolding(s) in Company
13th Nov 201410:48 amRNSNotification of Major Interest in Shares
11th Nov 20143:30 pmRNSHolding(s) in Company
6th Nov 20147:00 amRNSNotice of Results
10th Oct 20145:12 pmRNSHolding(s) in Company
1st Oct 201411:01 amRNSDirectorate Change
24th Sep 201410:21 amRNSDirector/PDMR Shareholding
22nd Sep 201411:54 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSChange of Broker
29th Jul 20142:14 pmRNSResult of AGM
29th Jul 20147:00 amRNSInterim Management Statement
17th Jul 201411:17 amRNSCompletion of acquisition and Total Voting Rights
11th Jul 201410:09 amRNSHolding(s) in Company
11th Jul 201410:08 amRNSHolding(s) in Company
10th Jul 20144:08 pmRNSTotal Voting Rights
10th Jul 20143:59 pmRNSHolding(s) in Company
9th Jul 201411:32 amRNSResult of Rump Placing
9th Jul 20147:00 amRNSResult of Rights Issue
1st Jul 20142:14 pmRNSDirector/PDMR Shareholding
27th Jun 201411:15 amRNSNotice of AGM
24th Jun 201412:13 pmRNSDirector/PDMR Shareholding
24th Jun 20147:00 amRNSAdmission of Nil Paids
23rd Jun 20141:30 pmRNSHolding(s) in Company
23rd Jun 201412:04 pmRNSResult of the General Meeting
20th Jun 201411:26 amRNSHolding(s) in Company
6th Jun 201412:28 pmRNSDirector/PDMR Shareholding
5th Jun 20145:04 pmRNSPublication of Prospectus
5th Jun 20148:34 amRNSPublication of Annual Report and Accounts
5th Jun 20147:05 amRNSAcquisition
5th Jun 20147:00 amRNSFinal Results
2nd Jun 20144:15 pmRNSCompletion of Transaction
2nd Jun 20144:00 pmRNSResult of General Meeting
15th May 20142:41 pmRNSPublication of Circular
15th May 20147:00 amRNSProposed Disposal of Supply Chain Business
10th Apr 20147:00 amRNSTrading Update
3rd Apr 201412:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.